Big multiple sclerosis data network: novel modelling approaches for real-world data analysis
Trojano, M., Iaffaldano, P., Copetti, M., Drahota, J., Forsberg, L., Mouresan, E.F., Pontieri, L., Spelman, T., Toschi, N., Butzkueven, H., et al. (2025). J Neurol (272). p.754

Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France
Wilson, S., Leray, E., Calocer, F., Rollot, F., Fauvernier, M., Remontet, L., Launay, L., Vukusic, S., Le Page, E., Debouverie, M., et al. (2025). BMC Neurol (25). p.441

Evaluation of a deep learning segmentation tool to help detect spinal cord lesions from combined T2 and STIR acquisitions in people with multiple sclerosis
Lodé, B., Hussein, B.R., Meurée, C., Walsh, R., Gaubert, M., Lassalle, N., Courbon, G., Martin, A., Le Bars, J., Durand-Dubief, F., et al. (2025). Eur Radiol (35). p.5954–5964

Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis
Gavoille, A., Nourredine, M., Rollot, F., Casey, R., Mathey, G., Kerbrat, A., Ciron, J., De Sèze, J., Stankoff, B., Maillart, E., et al. (2025a). J Neurol Neurosurg Psychiatry p.jnnp-2025-336762

Data linkage between the French multiple sclerosis cohort (OFSEP) and the French national health insurance database (SNDS)
Leray, E., Drezen, E., Casey, R., and Vukusic, S. (2025). Revue Neurologique (181). p.624–631

Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis
Gavoille, A., Leray, E., Marignier, R., Rollot, F., Casey, R., Mathey, G., Michel, L., De Seze, J., Ciron, J., Ruet, A., et al. (2025b). Neurology (105). p.e213907

Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis
Robin, C., Rollot, F., Lefort, M., Casey, R., Vukusic, S., Mathey, G., Ciron, J., De Seze, J., Stankoff, B., Maillart, E., et al. (2025). Neurology (105). p.e213744

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis
Gavoille, A., Rollot, F., Casey, R., Mathey, G., Le Page, E., Ciron, J., De Sèze, J., Ruet, A., Maillart, E., Labauge, P., et al. (2025c). JAMA Neurol

Optimizing treatment for pediatric multiple sclerosis
Benallegue, N., Rollot, F., and Laplaud, D.-A. (2025). Expert Rev Neurother (25). p.819–855

Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network
Lorscheider, J., Signori, A., Subramaniam, S., Benkert, P., Vukusic, S., Trojano, M., Hillert, J., Glaser, A., Hyde, R., Spelman, T., et al. (2025). J Neurol Neurosurg Psychiatry (96). p.606–615

Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM study
Cohen, M., Rollot, F., Debouverie, M., Zephir, H., Vukusic, S., De Seze, J., Labauge, P., Landes-Chateau, C., Mondot, L., Levraut, M., et al. (2025). Eur J Neurol (32). p.e16583

Prognostic factors of disability progression in multiple sclerosis in real life: the OFSEP-high definition (OFSEP-HD) prospective cohort in France
Guillemin, F., Casey, R., Epstein, J., Foucher, Y., Laplaud, D., Achit, H., Rollot, F., Leray, E., Vukusic, S., and OFSEP-HD investigators (2025). BMJ Open (15). p.e094688

LymphoTEC: a Retrospective Real-World Study on Lymphocyte Reconstitution After Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in France
de Sèze, J., Labauge, P., Liblau, R., Martinez, M., Moreau, T., Suchet, L., Vermersch, P., Vukusic, S., Mathey, G., Michel, L., et al. (2025). Adv Ther (42). p.1760–1782

Causal Inference in Presence of Intra-Patient Correlation due to Repeated Measurements of Exposure and Outcome in Longitudinal Settings
Gavoille, A., Rollot, F., Casey, R., Vukusic, S., Rabilloud, M., and Subtil, F. (2025d). Stat Med (44). p.e70037

Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population
Maillart, E., Rollot, F., Leray, E., Benyahya, L., Bourre, B., Carra-Dallière, C., Casey, R., Deiva, K., Girod, C., Guennoc, A.-M., et al. (2025). Mult Scler (31). p.324–337

Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis
Mainguy, M., Casey, R., Vukusic, S., Lebrun-Frenay, C., Berger, E., Kerbrat, A., Al Khedr, A., Bourre, B., Ciron, J., Clavelou, P., et al. (2025). Neurol Neuroimmunol Neuroinflamm (12). p.e200371

Evaluation of the predictive value of CSF-restricted oligoclonal bands on residual disability and risk of relapse in adult patients with MOGAD: MOGADOC study
Ramdani, R., Pique, J., Deschamps, R., Ciron, J., Maillart, E., Audoin, B., Cohen, M., Zephir, H., Laplaud, D., Ayrignac, X., et al. (2025). Mult Scler (31). p.290–302

MRI management of NMOSD and MOGAD: Proposals from the French Expert Group NOMADMUS
Durand-Dubief, F., Shor, N., Audoin, B., Bourre, B., Cohen, M., Kremer, S., Maillart, E., Papeix, C., Ruet, A., Savatovsky, J., et al. (2025). J Neuroradiol (52). p.101235

Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolution
Rodriguez, S., Couloume, L., Ferrant, J., Vince, N., Mandon, M., Jean, R., Monvoisin, C., Leonard, S., Le Gallou, S., Silva, N.S.B., et al. (2025). Front. Immunol. (15).

Association between education level and disability progression in patients with multiple sclerosis in France
Lefort, M., Dejardin, O., Berger, E., Camdessanché, J.-P., Ciron, J., Clavelou, P., De Sèze, J., Debouverie, M., Heinzlef, O., Labauge, P., et al. (2025a). Mult Scler (31). p.59–68

Association between education level and access to disease-modifying treatment in patients with multiple sclerosis in France
Lefort, M., Dejardin, O., Berger, E., Camdessanché, J.-P., Ciron, J., Clavelou, P., De Sèze, J., Debouverie, M., Heinzlef, O., Labauge, P., et al. (2025b). Mult Scler (31). p.69–80